Cefoperazone & Sulbactam Injection Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness exports Cefoperazone & Sulbactam Injection for serious bacterial infections requiring injectable broad-spectrum antibacterial therapy in hospital and critical care settings. The formulation is extensively administered in septicemia, intra-abdominal infections, respiratory tract infections, post-surgical infections, and complicated urinary bacterial conditions.

Cefoperazone belongs to the third-generation cephalosporin antibiotic class and acts against a wide range of bacterial pathogens, while Sulbactam enhances antibacterial potency by neutralizing beta-lactamase resistance enzymes. As a recognized Critical Care Injectable Exporter, Genliva Wellness develops sterile injectable formulations intended for advanced hospital infection management.

Operating as a Cefoperazone Sulbactam Injection Manufacturer in India, Genliva Wellness LLP supplies injectable antibiotic formulations to pharmaceutical distributors and international healthcare institutions.

Cefoperazone & Sulbactam Injection is formulated for severe hospital bacterial infection treatment.

Third-generation cephalosporin sterile injection
Targets beta-lactamase producing bacterial strains
Administered in ICU and emergency care settings
Manufactured under controlled sterile conditions
Delivers enhanced antibacterial potency
Developed for injectable hospital therapies

This injectable formulation is administered in severe bacterial infection management.

Treatment of septicemia and respiratory infections
Management of post-surgical bacterial complications
Prescribed in intra-abdominal infections
Administered in complicated urinary bacterial conditions
Targets resistant hospital-acquired bacterial organisms
Used in critical care antibacterial protocols

Cefoperazone & Sulbactam Injection delivers advanced injectable antibacterial therapy for critical infections.

Acts against resistant bacterial pathogens
Frequently administered in hospital infection management
Enhances antibacterial action through beta-lactamase inhibition
Rapid injectable administration in severe infections
Valuable in ICU antibacterial treatment protocols
Maintains strong antibacterial coverage in critical care